Opalong, Ace Gabriel .

HRN: 15-54-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFUROXIME 750MG (VIAL)
10/29/2025
11/04/2025
IV
700mg
Q8h
Empiric
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: